ADRB2 and chronic obstructive pulmonary disease: Inhaled β2-adrenergic receptor (β2AR) agonists are efficacious bronchodilators that are used clinically in patients with pulmonary disorders such as asthma or chronic obstructive pulmonary disease (COPD), the hypercontractility of which is linked to pulmonary inflammation and a highly oxidative environment.